Biogen Inc
(BIIB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 626,757 | 720,962 | 639,559 | 581,889 | 585,788 |
| Marketable Securities | 197,835 | 248,710 | 513,115 | 681,835 | 821,888 |
| Receivables | 616,697 | 548,893 | 560,777 | 551,208 | 550,995 |
| Inventories | 269,313 | 267,878 | 280,038 | 293,950 | 278,686 |
| Other current assets | 420,529 | 468,788 | 415,523 | 371,713 | 334,902 |
| TOTAL | $2,131,131 | $2,255,231 | $2,409,012 | $2,480,595 | $2,572,259 |
| Non-Current Assets | |||||
| PPE Net | 1,641,791 | 1,571,521 | 1,604,573 | 1,637,083 | 1,634,696 |
| Investments And Advances | 767,262 | 767,848 | 1,242,984 | 1,424,477 | 1,753,746 |
| Intangibles | 2,853,963 | 2,907,550 | 2,960,754 | 3,009,699 | 3,065,736 |
| TOTAL | $5,263,016 | $5,246,919 | $5,808,311 | $6,071,259 | $6,454,178 |
| Total Assets | $7,394,147 | $7,502,150 | $8,217,323 | $8,551,854 | $9,026,437 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 143,699 | 144,476 | 121,356 | 118,534 | 108,547 |
| Accrued Expenses | 553,796 | 487,803 | 432,887 | 500,755 | 537,408 |
| TOTAL | $824,480 | $755,658 | $682,330 | $714,942 | $721,368 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,068,776 | 1,069,725 | 1,076,201 | 1,080,207 | 1,085,844 |
| Other Non-Current Liabilities | 398,011 | 256,774 | 256,749 | 253,846 | 329,822 |
| TOTAL | $1,499,466 | $1,535,202 | $1,584,399 | $1,575,030 | $1,707,259 |
| Total Liabilities | $2,323,946 | $2,290,860 | $2,266,729 | $2,289,972 | $2,428,627 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 238,302 | 241,915 | 266,998 | 269,601 | 289,199 |
| Common Shares | 124 | 129 | 139 | 144 | 149 |
| Retained earnings | 1,646,852 | 1,405,340 | 1,131,523 | 1,068,890 | 781,321 |
| Other shareholders' equity | 30,535 | 12,082 | 64,467 | 90,928 | 71,025 |
| TOTAL | $5,070,201 | $5,211,290 | $5,950,594 | $6,261,882 | $6,597,810 |
| Total Liabilities And Equity | $7,394,147 | $7,502,150 | $8,217,323 | $8,551,854 | $9,026,437 |